MASTERINVEST Kapitalanlage GmbH acquired a new stake in shares of Amgen Inc. (NASDAQ:AMGN - Free Report) in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor acquired 11,907 shares of the medical research company

North Star Asset Management Inc. purchased a new position in shares of Amgen Inc. (NASDAQ:AMGN - Free Report) in the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 10,471 shares of the medical

Empowered Funds LLC purchased a new stake in shares of Amgen Inc. (NASDAQ:AMGN - Free Report) during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor purchased 95,907 shares of the medical research company

Pacific Heights Asset Management LLC purchased a new position in shares of Amgen Inc. (NASDAQ:AMGN - Free Report) during the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 90,000 shares of the medical research company

Redwood Investment Management LLC bought a new position in Amgen Inc. (NASDAQ:AMGN - Free Report) during the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 2,400 shares of the medical research company

Jefferies Financial Group Inc. acquired a new position in shares of Amgen Inc. (NASDAQ:AMGN - Free Report) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 239,779 shares of the medical research compan

Valueworks LLC acquired a new position in Amgen Inc. (NASDAQ:AMGN - Free Report) during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 10,978 shares of the medical research company

Equitable Holdings Inc. bought a new position in shares of Amgen Inc. (NASDAQ:AMGN - Free Report) in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 24,845 shares of the medical research company

Coastal Bridge Advisors LLC acquired a new position in shares of Amgen Inc. (NASDAQ:AMGN - Free Report) in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 14,287 shares of the medical research company